A study on GLP1RA medications found that behavioral side effects likely do not result from direct action on GLP1R.

An observational analysis has found that the drugs may lower the risk of substance abuse and cognitive issues. But the ...

This article explores methods to enhance efficiency in the drug discovery and development pipeline, focusing on optimizing ...

Positive data for Veru Inc.’s enobosarm lend more weight to the potential progress of the company’s body-mass preservation program in patients taking Wegovy (semaglutide). Top-line data of the phase ...

The glucagon-like peptide-1 receptor agonists improve glycemia and induce a modest weight loss, but there are doubts over their long-term safety. New drugs such as lorcaserin and phentermine ...

HONG KONG, Jan 28 (Reuters Breakingviews) - DeepSeek has triggered a dramatic rethink on artificial intelligence spending around the world, except perhaps in China. The startup's impressive low ...